KalVista Pharmaceuticals (NASDAQ:KALV) PT Raised to $24.00 at HC Wainwright
KalVista Pharmaceuticals (NASDAQ:KALV – Free Report) had its price target upped by HC Wainwright from $16.00 to $24.00 in a research note issued to investors on Wednesday, Benzinga reports. HC Wainwright currently has a buy rating on the specialty pharmaceutical company’s stock. Separately, Needham & Company LLC lifted their price objective on shares of KalVista […]
More Stories
Community Health Systems (NYSE:CYH) Upgraded to Hold at StockNews.com
StockNews.com upgraded shares of Community Health Systems (NYSE:CYH – Free Report) from a sell rating to a hold rating in...
Top Ships (NASDAQ:TOPS) Now Covered by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Top Ships (NASDAQ:TOPS – Free Report) in a research note released on Friday. The...
StockNews.com Downgrades Accuray (NASDAQ:ARAY) to Hold
StockNews.com lowered shares of Accuray (NASDAQ:ARAY – Free Report) from a buy rating to a hold rating in a research...
StockNews.com Downgrades WPP (NYSE:WPP) to Hold
WPP (NYSE:WPP – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold”...
Canterra Minerals (CVE:CTM) Trading 5% Higher – Should You Buy?
Canterra Minerals Co. (CVE:CTM – Get Free Report)’s share price traded up 5% during trading on Monday . The company...
Johnson Controls International plc (NYSE:JCI) Short Interest Down 13.0% in October
Johnson Controls International plc (NYSE:JCI – Get Free Report) saw a large decrease in short interest in the month of...